Intracellular antibiotics

Slides:



Advertisements
Similar presentations
Karmanshah, Iran, 24 May 20111st International and 12th Iranian Congress of Microbiology 1 Hunting intracellular bacteria with antibiotics Paul M. Tulkens,
Advertisements

5/20/2015ISAP Is the cellular accumulation of antibiotics a predictive factor for intracellular efficacy ? Sandrine Lemaire Université catholique.
Obligate Intracellular Organisms. Bacterial Intracellular Organisms Intracellular organism Lives in a phagosome & prevents phagolysosomal fusion Escapes.
PK/PD - ICC - Manila, June 5th, The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul.
Clinical implications of tissue concentrations Ursula Theuretzbacher Center for Anti-Infective Agents, Vienna, Austria Clinical Issues of PK/PD, ECC, Firenze.
Intracellular Pharmacodynamics: a Journey from Cell biology to the Design of New Chemotherapeutic Agents Paul M. Tulkens, MD, PhD Cellular and Molecular.
MACROLIDES: pharmacokinetics and pharmacodynamics
DNA gyrase inhibitors Quinolones
Hunting intracellular bacteria with antibiotics
Bacterial persistence
Setting-up a model of intracellular infection by Pseudomonas aeruginosa for the pharmacodynamic evaluation of antibiotic activity. J. Buyck1, O. Jolois2,
studies with Caco-2 cells and THP-1 macrophages
Intracellular Killing: Where’s the Bug? / Where’s the Drug?
Protein Synthesis Inhibitors
A-052 Antibiotic (AB) activity against Pseudomonas aeruginosa (PA) with Normal or Mucoïd Phenotypes in an Artificial Sputum Medium (ASM) in vitro Biofilm.
International Society for Anti-infective Pharmacology (ISAP)
Intracellular Infection of THP-1 Human Macrophages by Staphylococcus aureus and Role of Haemolysins Mailling adresse: Aurélie Olivier.
Comparison of the intracellular and extracellular activities of approved and novel antistaphylococcal antibiotics using a pharmacodynamic model exploring.
Intracellular antibiotics and Listeria monocytogenes
Françoise Van Bambeke & Paul M. Tulkens
In vitro pharmacodynamic models for the study of antibiotic activity against bacterial biofilms Françoise Van Bambeke, PharmD, PhD Pharmacologie cellulaire.
Frédéric Peyrusson, Françoise Van Bambeke, Paul M. Tulkens
Intracellular Antibiotics : what does it (really) mean ?
Accumulation, Release and Subcellular Distribution of the Peptide Deformylase Inhibitor GSK in Murine Macrophages (J774) and Human Monocytes (THP-1)
Activity of 9 antibiotics against intracellular forms of S. pneumoniae
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place ? Paul M. Tulkens Cellular and Molecular.
Azalides revisited: Why the single dose ? The pharmacologist's answer … Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of.
This poster will be made available for download after the meeting at :
Intracellular Bacterial Infections: Why Are Antibiotics Poorly Efficient and Can We Do Something About it ? Paul M. Tulkens, MD, PhD * Cellular and Molecular.
Université catholique de Louvain
Introduction Results Aim Methods References Conclusion
Co-medications Improve Moxifloxacin (MXF) Activity in Models of Pneumococcal Naïve and Induced Biofilms (BF) N. M. Vandevelde1, M. Van Obbergh1, P.M. Tulkens1,
Background and objectives
Activity and Pharmacodynamic (PD) Evaluation of Ceftazidime-Avibactam (CAZ-AVI) against Extracellular and Intracellular Forms of CAZ-susceptible and CAZ-resistant.
Université catholique de Louvain, Brussels, Belgium
Emilien Drouot, Paul M. Tulkens, Françoise Van Bambeke
Julien Buyck, Paul M. Tulkens and Françoise Van Bambeke
Antibiotic efflux pumps in eucaryotic cells: consequences for activity against intracellular bacteria Françoise Van Bambeke on behalf of J.M. Michot,
Paul M. Tulkens, MD, PhD Cellular and Molecular Pharmacology Unit
Extracellular activity Intracellular activity
Antibiotics in bone and joint infections
Abstract Results Methods Background Conclusions References
cellular accumulation (24h) Cstatic (LZD/RDZ ratio)
Incubation (with antibiotic)
52 - Antimicrobials Radezolid (RX-1741), a Novel Oxazolidinone, Accumulates Extensively within Human Macrophages and PMNs and Shows Activity towards.
Of a Pig-related ST-398 Methicillin-Resistant S. aureus (A-MRSA)
EV0626 Cellular pharmacokinetics of gepotidacin (GSK )
Abstract Results Aim of the study Methods Background Conclusions
Difference log CFU from time 0
Electron microscopy: intracellular infection of THP-1 by S. aureus
Log extracellular concentration (mg/L)
Activity of Moxifloxacin against Staphylococcus aureus in Models of Persistent Infections (Intracellular Survival, Biofilms) Mailing address: P.M. Tulkens.
F. Van Bambeke & P.M. Tulkens
Inhibiting efflux pumps to restore antibiotic activity against Pseudomonas aeruginosa Unité de Pharmacologie cellulaire et moléculaire F. Van Bambeke.
An overview of bacterial mechanisms for pathogenicity.
Antibiotics in 2005: Which one do we need to use and when ?
Rega Institute : my research contacts …
M.P. Mingeot-Leclercq, P.M. Tulkens, F. Van Bambeke
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
Françoise Van Bambeke, Dr Sc. Pharm, Agr. Ens. Sup.
Intracellular models of infection to evaluate antibiotic activity
Models of Intracellular Antibiotic Transport
Chemotherapy and PK/PD of intracellular infections
Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with.
conformational change
Pharmacodynamic indices in targeting therapy of critical infections
Setting-up of a 24 h model to evaluate the activity of antibiotics against intracellular forms of S. aureus infection C. Seral, M. Barcia-Macay, F. Van.
Are intracellular drug concentrations relevant for efficacy
Fluoroquinolone Nalidixic acid is the predecessor to all fluoroquinolones, a class of man-made antibiotics. Fluoroquinolones in use today typically offer.
Presentation transcript:

Intracellular antibiotics D D* Paul M. Tulkens, MD, PhD Françoise Van Bambeke, Pharm., PhD in collaboration with Cristina Seral, Pharm., PhD Stéphane Carryn, Pharm., PhD Hugues Chanteux, Pharm., PhD Sandrine Lemaire, BSc. Cellular and Molecular Pharmacology Catholic University of Louvain, Brussels, Belgium www.facm.ucl.ac.be Magic Bullets ... 10/09/2004

Why intracellular antibiotics ? The Cell antibiotic bacteria Black Box... Magic Bullets ... 10/09/2004

Which bacteria … and which diseases ... Obligatory or mainly intracellular: respiratory infections (pneumopathies): Chlamydia pneumoniae: 10% in children Legionella pneumophila: frequent if immunosuppression Mycobacterium spp.: frequent if immunosuppression sexually transmitted diseases Chlamydia trachomatis: most common pathogen CNS infections + other sites: Listeria monocytogenes: pregnant women; immunosuppression Facultative or mainly extracellular: digestive tract infections Salmonella spp., Shigella spp. respiratory, cutaneous, etc…tract infections Streptococcus spp., Staphylococcus spp. etc... Magic Bullets ... 10/09/2004

Subcellular localization of antibiotics ? cytosol fluoroquinolones beta-lactams ansamycins macrolides (1/3) ? endosomes phagosomes phago- lysososomes lysososomes macrolides (2/3) aminoglycosides Magic Bullets ... 10/09/2004

Mechanisms of localisation and accumulation ... cytosol fluoroquinolones Mechanism unknown (loose binding to lipids / lipoproteins ? …) Efflux demonstrated (MRP ?) Magic Bullets ... 10/09/2004

Mechanisms of localisation and accumulation ... proton trapping binding to phospholipids for aminoglycosides: inability to cross membranes lysososomes macrolides aminoglycosides Magic Bullets ... 10/09/2004

Subcellular bioavailability of antibiotics ? High Fair Nil FQ / Ansamyc. / cytosol. ML lysosom. ML / AG Magic Bullets ... 10/09/2004

Subcellular bioavailability of antibiotics ? Fluoroquinolones move easily across membranes FQ Magic Bullets ... 10/09/2004

Subcellular bioavailability of antibiotics ? aminoglycosides and lysosomal macrolides reamain largely if not totally sequestered in an acidic environment ... Magic Bullets ... 10/09/2004

Listeria monocytogenes Illustration: the Listeria story antibiotics: ampicillin/meropenem azithromycin sparfloxacin/moxifloxcin pivampicillin Listeria monocytogenes hly+ Magic Bullets ... 10/09/2004

Intracellular infection cycle of Listeria monocytogenes hly+ from Portnoy et al. Magic Bullets ... 10/09/2004

Following the intracellular fate of Listeria m. by EM in cytosol escape from vacuole phagocytosis Magic Bullets ... 10/09/2004

1st question: is there a simple relation between MIC, accumulation and intracellular activity (5 h model) MIC AMPI AZ SP 0.0 0.5 1.0 1.5 Accumulation AMPI AZ SP 25 50 75 100 Activity * AMPI AZ SP 0.0 0.5 1.0 1.5 *  log CFU 5h Ce = 10 x MIC Ouadhriri et al., AAC,1999 Magic Bullets ... 10/09/2004

Listeria m. and ampicillin Ampicillin is poorly active against intracellular Listeria m. in spite of its favourable MIC; lack of accumulation ... Why do you keep ampicillin ? extracellular bacteria get intracellular activity with very large doses ?? (but -lactams are NOT dose-dependent…) but may be you just have to wait ... Magic Bullets ... 10/09/2004

-lactams become bactericidal intracellularly after 24h and if you give a dose high enough -2 -1 1 2 3 ampicilline méropénème Multiples of MIC (log10) Change from original inoculum (log10) (Lemaire et al, 2004, unpublished (Carryn et al., 2003, JAC 51:1051-52 Magic Bullets ... 10/09/2004

Listeria m. and azithromycin Azitromycin is poorly active against intracellular Listeria m. in spite of its exceptionally large intracellular concentration most azithromycin is trapped in lysosomes azithromycin is poorly bactericidal Is there a future for macrolides ? Magic Bullets ... 10/09/2004

Listeria m. and fluoroquinolones In a pharmacological model*, fluoroquinolones appear most active in spite of relatively unfavourable MICs and modest cellular accumulation compared to macrolides … Fluoroquinolones have a large subcellular bioavailability are highly bactericidal * all Ce = 10 X the MIC Magic Bullets ... 10/09/2004

Comparative intracellular activities at multiples of Cmax -2.5 -2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5 25 50 75 100 ampicillin moxifloxacin Change from original inoculum ( D log) (Carryn et al., 2002, AAC 43:2095-103) Moxifloxacin is profoundly bactericidal at clinically achievable concentrations Magic Bullets ... 10/09/2004

broth cells However, intracellular moxifloxacin is NOT more active intracellularly than extracellularly when using the extracellular concentration as comparison basis ... Carryn et al., AAC, 2002 Magic Bullets ... 10/09/2004

And this is obvious if you compare intracellular and extracellular activities at the same apparent concentration * / MIC ratio …. 1 extracellular levofloxacine moxifloxacine log CFU (5 h - 0h) intracellular levofloxacine -1 moxifloxacine  Seral et al., unpublished -2 0.1 1 10 100 extracellular = actual intracellular = calculated concentration / MIC Magic Bullets ... 10/09/2004

A basic prodrug of a -lactam ? pH 7.4 pH 7.0 pH 5.4 Proton pump ProD ProD ProDH+ H+ D Magic Bullets ... 10/09/2004

regenerate ampicillin Basic compounds that H2N Phthalimidomethylampicillin (PIMA) regenerate ampicillin accumulate in J774 macrophages Fan et al, Bioorg. Med. Chem. Let.1997 Pivaloyloxymethylampicillin (PIVA) Paternotte et al, Biorg. Med. Chem. 2001 Magic Bullets ... 10/09/2004

Intracellular activity for extracellular concentrations of ... PIVA PIMA 10X MIC CFU/mg prot Time (h) Same activity for PIVA, PIMA and AMPI 0.5X MIC Only PIVA is active CTRL AMPI Magic Bullets ... 10/09/2004 Chanteux et al, JAC, 2003

But maintains it if the medium is renewed every 5 h At low extracellular concentration, PIVA loses its activity after 5 h if the medium is not renewed 5 10 15 20 4 6 8 CTRL Extracellular concentration PIVA 0.5X MIC CFU/mg prot But maintains it if the medium is renewed every 5 h Time (h) Magic Bullets ... 10/09/2004 Chanteux et al, JAC, 2003

PIVA releases large amount of intracellular ampicillin 5 10 15 20 25 30 AMPI from PIVA AMPI from AMPI AMPI from PIVA with changes of medium) Time (h) Cc/Ce Chanteux et al, JAC, 2003 Magic Bullets ... 10/09/2004

The seven pillars of intracellular / intratissular activity ? D* 4 4. Subcell. bioavailability 7 7. Cooper. with host def. D 1 1. Penetration D 3. Accumulation 3 5 5. Expression of activity 2 2. No efflux 6. Bacterial responsiveness and pharmacodynamics 6 Magic Bullets ... 10/09/2004

The 6 pillars of intracellular / intratissular accumulation and activity of antibiotics... Hugues Chanteux 4 Christina Seral D D 2 D Françoise Van Bambeke Stéphane Carryn 5 Sandrine Lemaire Françoise Van Bambeke, Stéphane Carryn, Cristina Seral, Hugues Chanteux, Sandrine Lemaire ... Magic Bullets ... 10/09/2004